These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 17059910

  • 21. Diagnosis and treatment of gouty arthritis.
    TALBOTT JH.
    Calif Med; 1953 Sep; 79(3):220-6. PubMed ID: 13082423
    [Abstract] [Full Text] [Related]

  • 22. A survey of current evaluation and treatment of gout.
    Schlesinger N, Moore DF, Sun JD, Schumacher HR.
    J Rheumatol; 2006 Oct; 33(10):2050-2. PubMed ID: 17014020
    [Abstract] [Full Text] [Related]

  • 23. Gout: why is this curable disease so seldom cured?
    Doherty M, Jansen TL, Nuki G, Pascual E, Perez-Ruiz F, Punzi L, So AK, Bardin T.
    Ann Rheum Dis; 2012 Nov; 71(11):1765-70. PubMed ID: 22863577
    [Abstract] [Full Text] [Related]

  • 24. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R, Mody RR, Fuldeore MJ, Patel PA, Mikuls TR.
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The side effects of allopurinol.
    Wallach SL.
    Hosp Pract (1995); 1998 Sep 15; 33(9):22. PubMed ID: 9750548
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Arthroscopic elimination of monosodium urate deposition of the first metatarsophalangeal joint reduces the recurrence of gout.
    Wang CC, Lien SB, Huang GS, Pan RY, Shen HC, Kuo CL, Shen PH, Lee CH.
    Arthroscopy; 2009 Feb 15; 25(2):153-8. PubMed ID: 19171274
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. DIABETES MELLITUS IN PATIENTS WITH GOUTY ARTHRITIS.
    ISHMAEL WK, OWENS JN, PAYNE RW, HONICK MD.
    JAMA; 1964 Oct 26; 190():396-8. PubMed ID: 14197986
    [No Abstract] [Full Text] [Related]

  • 34. [Conservative urate stone therapy].
    Frick J.
    Wien Klin Wochenschr; 1966 Nov 25; 78(47):833-4. PubMed ID: 5994701
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Uricosuric agents in the management of chronic tophaceous gout with renal impairment.
    MORRIS JB.
    N Z Med J; 1961 Aug 25; 60():390-2. PubMed ID: 14476250
    [No Abstract] [Full Text] [Related]

  • 37. Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis.
    GUTMAN AB, YU TF.
    Trans Assoc Am Physicians; 1951 Aug 25; 64():279-88. PubMed ID: 14884260
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [CASE OF CHRONIC TOPHOCEOUS GOUT].
    ITO H, OKAZAKI M, AKAOKA I, KOYAMA S.
    Iryo; 1963 Dec 25; 17():736-40. PubMed ID: 14123823
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.